Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravenous VAL-1221 Lafora Expanded Access Protocol (LEAP)

NCT05930223 is registered in ClinicalTrials.gov with Parasail, LLC as lead sponsor.

NCT NCT05930223
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05930223 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravenous VAL-1221 Lafora Expanded Access Protocol (LEAP)
Lead sponsor
Parasail, LLC
Phase
Expanded access
Overall status
Available
Start date
Not reported
Completion date
Not reported
Enrollment
Not reported
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

lafora disease